Events

Welcome to a guest lecture by Dr. Stephen Beers, Professor of Immunology & Immunotherapy, University of Southampton, UK

This breakfast meeting is hosted by Ludvig Munthe's group

At the March Breakfast meeting, we will launch the PRIMA Mentorship program 

Welcome to a distinguished guest lecture by Prof. Ronald Germain, NIH. Prof. Germain is part of the Scientific Advisory Board of PRIMA, and will share his exciting work on deciphering immune responses with in situ imaging. The event is hosted by PRIMA and the Norwegian Society of Immunology (NSI)

Our Scientific Advisory Board will attend the breakfast meeting and we will have presentations from our task forces

Welcome to a seminar with Magnus Essand and Anna Dimberg from Uppsala University on CAR-T cell clinical trials for B cell lymphoma and glioblastoma, and the role of vascularization and tumor micro environment for efficient anti-tumor T cell responses in glioblastoma

PRIMA is hosting a visit from BioInvent, a clinical-stage company that discovers and develops antibodies for cancer therapy. Based on extensive knowledge in immunology, cancer biology and antibody biology, BioInvent generates innovative immuno-oncology drug candidates. CSO Björn Frendéus will give a talk focusing on how antibodies are used as treatments and the importance of cutting edge science in collaboration between academia and industry to generate new and safe therapeutics.

Welcome to the January Breakfast meeting Wednesday Jan 17 at 8:30!

Welcome to the December Breakfast meeting! The Spatial Biology Task force has put together a great program

From the Nobel Committee at Karolinska Institutet on awarding the Nobel Prize in Physiology or Medicine 2023 to Katalin Karikó og Drew Weissmann:

"When the pandemic broke in early 2020, mRNA companies acted quickly to develop COVID-19 vaccines. BioNTech and Moderna chose to use mRNA with modified bases building on the discoveries by Karikó and Weissmann. BioNTech, with Uğur Şahin and Özlem Türeci in the lead, worked in partnership with Pfizer"

This essential work served humanity during the COVID-19 pandemic. Read more about the Nobel Prize in Medicine or Physiology 2023 

 Nebojsa Janjic, Ph.D., the Chief Science Officer at SomaLogic

Welcome to the November Breakfast meeting! The Target identification Task force has put together a great program